Lilly's $1.6bn cancer drug draws blank in pancreatic cancer ...

Eli Lilly is looking at other uses for its new cancer immunotherapy pegilodecakin after it flopped in a phase 3 pancreatic cancer trial.

FDA approves Lilly's new migraine attack drug, rival from Al...

The FDA has approved Eli Lilly’s new migraine drug lasmiditan, offering patients a new option to relieve symptoms should they feel an attack coming on.

Humira tops list of drugs with unwarranted US price hikes

Xeris’ severe low blood sugar pen gets FDA approval

Relief for Lilly as drug from $8bn Loxo deal clears pivotal ...

Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimt...